MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics, Inc. (INDP)
source: myfinsight.com
Download
Download image
Net change in cash
and cash...
-$7,009,993
Warrant repricing
$410,154
Stock-based compensation
$227,180
Prepaid expenses and
other current assets
-$119,319
Net cash used in
operating activities
-$7,009,993
Canceled cashflow
$756,653
Accounts payable and
other current...
-$5,225,576
Net loss
-$2,541,070
Back